14-100337086-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_004184.4(WARS1):c.1230C>T(p.Asp410Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00498 in 1,614,032 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0062 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0049 ( 28 hom. )
Consequence
WARS1
NM_004184.4 synonymous
NM_004184.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0610
Genes affected
WARS1 (HGNC:12729): (tryptophanyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. Tryptophanyl-tRNA synthetase (WARS) catalyzes the aminoacylation of tRNA(trp) with tryptophan and is induced by interferon. Tryptophanyl-tRNA synthetase belongs to the class I tRNA synthetase family. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 14-100337086-G-A is Benign according to our data. Variant chr14-100337086-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1879286.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr14-100337086-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.061 with no splicing effect.
BS2
High AC in GnomAd4 at 943 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WARS1 | NM_004184.4 | c.1230C>T | p.Asp410Asp | synonymous_variant | 10/11 | ENST00000392882.7 | NP_004175.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WARS1 | ENST00000392882.7 | c.1230C>T | p.Asp410Asp | synonymous_variant | 10/11 | 1 | NM_004184.4 | ENSP00000376620.2 |
Frequencies
GnomAD3 genomes AF: 0.00616 AC: 937AN: 152168Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
937
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00542 AC: 1363AN: 251460Hom.: 8 AF XY: 0.00563 AC XY: 765AN XY: 135898
GnomAD3 exomes
AF:
AC:
1363
AN:
251460
Hom.:
AF XY:
AC XY:
765
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00485 AC: 7096AN: 1461746Hom.: 28 Cov.: 33 AF XY: 0.00491 AC XY: 3570AN XY: 727180
GnomAD4 exome
AF:
AC:
7096
AN:
1461746
Hom.:
Cov.:
33
AF XY:
AC XY:
3570
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00619 AC: 943AN: 152286Hom.: 6 Cov.: 33 AF XY: 0.00673 AC XY: 501AN XY: 74458
GnomAD4 genome
AF:
AC:
943
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
501
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
WARS1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | WARS1: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at